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OBJECTIVES Carotid artery remodeling, also deﬁned as intima-media
thickening, is an important predictive indicator for human cardio-
vascular disease. Chronic changes in shear stress contribute to
vascular remodeling. Orphan nuclear receptor Nur77 is expressed in
diseased human vascular tissue, and plays a critical role in vascular
physiology and pathology. In this study, we aim to deﬁne the
exact role of Nur77 in vascular remodeling induced by low shear
stress.
METHODS Low shear stress-induced carotid artery remodeling was
induced by partial ligation of left common carotid artery in 6-8-week-old
C57BL/6 mice. After 4 weeks, the left common carotid arteries were har-
vested. The morphology of remodeling arteries was detected by HE
staining, Verhoeff-Van Gieson elastic staining, and Picro Sirius-Red
staining for collagen. The expression of Nur77 protein in ligated arteries
was observed by immunoﬂuoescence staining. Primary rat vascular
smooth muscle cells (VSMCs) were cultured and stimulated with platelet-
derived growth factor (PDGF) and H2O2 in vitro. The mRNA and protein
expression of Nur77 was detected by Real-time PCR, Western blotting and
immunoﬂuorescence staining. ROS level was assessed by DCFH-DA
staining. To investigate the effect of Nur77 on VSMCs proliferation and
migration, rat VSMCs were overexpressed Nur77 by adenovirus infection.
For further investigation the in vivo role of Nur77 in carotid artery
remodeling, wild type (WT) and Nur77-deﬁcient mice were subjected to
partial ligation of the left common carotid artery. The morphology of
remodeling arteries was detected as mentioned above. In situ
matrix metallopeptidase 9 (MMP-9) activities were detected by immu-
noﬂuorescence staining. The proliferation and apoptosis of VSMCs in
remodeling arteries were examined by PCNA and TUNEL staining,
respectively.
RESULTS Following vascular remodeling, Nur77 is highly expressed in
neointimal VSMCs in ligated carotid arteries. ROS levels were elevated
both in remodeling arteries in vivo and after PDGF stimulation in pri-
mary rat VSMCs in vitro. Further in vitro experiments indicate that
Nur77 is rapidly induced in VSMCs by PDGF and H2O2, while NAC
treatment attenuates the increased protein level of Nur77 by H2O2.
Moreover, Nur77 overexpression markedly inhibited VSMCs prolifera-
tion and migration induced by PDGF. In vivo, Nur77-deﬁcient mice
showed increased intima-media area and intima-media thickness in
ligated carotid arteries, as well as more severe elastin disruption
and collagen deposition compared to WT mice. Immunoﬂuorescence
staining indicates an upregulation of VSMC proliferation and
MMP-9 production of intima area in Nur77-deﬁcient mice. There
was no difference in the number of intimal apoptotic cells between
groups.
CONCLUSIONS Taken together, our results indicate that Nur77 may
be a sensor of oxidative stress and an inhibitor of vascular remodeling
induced by low shear stress. Nur77 as well as its downstream cell
signals might be a potential therapeutic target for the suppression of
vascular remodeling.
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OBJECTIVES With the advent of dual-source cardiac computed to-
mography (DSCT) imaging, three-dimensional (3D) modeling software
and 3D printers, rapid prototype constructions of congenital cardiac
defects are now possible. Typically, source images for previouslyreported models derive from retrospectively electrocardiography
(ECG)-gated CT angiography to acquire higher resolution imaging,
which may involve higher ionizing radiation, especially for infants.
New prospectively ECG-triggering protocol with short acquisition
window has optimized low dose CT images for 3D heart model
printing. Thus, the objectives of this study were to conﬁrm the
feasibility of creating cardiac models from low dose CT data and to
assess accuracy by comparing 3D model measurements with intra-
operative measurements of cardiac malformations.
METHODS Seven preoperative infants undergoing the low dose car-
diac DSCT scanning with prospectively ECG-triggering protocol with
acquisition window of 200 ms were identiﬁed, of whose principal
diagnose were two with Tetralogy of Fallot, one with complete
transposition of great artery, one with supracardiac total anomalous
pulmonary venous drainage, one with double outlet right ventricle,
one with complete endocardial cushion defect, and one with truncus
arteriosus. Raw CT data were exported anonymously and converted to
Digital Imaging and Communications in Medicine format. The image
data were then imported into segmentation software to create a 3D
digital model, and printed. The intraoperative ﬁndings and mea-
surements of cardiac malformations were set as reference standards.
Identiﬁcation and measurements of the cardiac malformations from
the 3D model were compared with reference standards, by meticu-
lously double-blind manners.
RESULTS Seven infants (median 11 months old, range 6-27 months)
were found 44 malformations with 10 atrial or ventricular septal
defects during surgeries. Seven heart models were printed with all
good appearances, and demonstrated 34 malformations with score
A (77.3%, ﬁne), 8 with score B (18.2%, average), 2 with score C
(4.5%, missed), and 0 with score D (0, wrong). Measurements of
atrial or ventricular septal defects were obtained. Meanstandard
deviation values for the 3D model and intraoperative measurements
were 8.54.0 and 8.73.9 mm respectively (P >0.05), indicating no
signiﬁcant differences between the 3D printing and real heart mea-
surements. The two groups were highly correlated, with a Pearson
correlation coefﬁcient of 0.980. The mean absolute error (3D vs real)
for each measurement was 0.690.44 mm, indicating accuracy of
the 3D model of < 1 mm.
CONCLUSIONS Three-dimensional heart model printing of complex
congenital heart disease based on the low dose cardiac CT images are
technically feasible and may accurately reﬂect cardiac malformation
anatomy. Three-dimensional models derived from low dose cardiac
CT data represent a new tool in procedural planning for infants with
congenital heart disease.GW26-e3978
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OBJECTIVES The renin-angiotensin system (RAS) regulates body
ﬂuid balance, renal functions and blood pressure. Angiotensin-con-
verting enzyme 2 (ACE2) is now known as a negative regulator of RAS,
and activation of the ACE2 is a possible alternative target for new
drugs, since some protective inﬂuences on renal and cardiovascular
function have been revealed. We hypothesized that ACE2 would exert
beneﬁcial effects on oxidative stress levels and renal injury in apoli-
poprotein E (ApoE) -knockout (KO) mice.
METHODS In this study, we used 12-week-old wild-type, ApoEKO,
and ACE2/ApoE double KO mice. The ApoEKO mice were treated
with recombinant human ACE2 (hrACE2) with the daily dose of
2 mg/kg. We characterized the functional, structural and molecular
signaling changes in mice kidneys by quantitative real-time reverse
transcription PCR, Western blotting, ROS ﬂuorescent probe dihy-
droethidium staining and transmission electron microscope analysis,
respectively.
RESULTS Compared with the ApoEKO mice, ACE2 deﬁciency led to
greater increases in renal oxidative stress levels and expression of
oxidative stress-inducible proteins NADPH oxidase 4 (NOX4) in the
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erbation of renal tubule ultrastructure injury and greater activation of Akt
and ERK1/2 phosphorylated signaling. Conversely, treatment with hrACE2
signiﬁcantly attenuated renal oxidative stress levels and ultrastructure
injury, and prevented the expression of NOX4 and phosphorylated level
of Akt and ERK1/2 in ApoEKO mouse kidneys. However, there were no
changes in renal expression of NOX2 among groups.
CONCLUSIONS Deletion of ACE2 triggers greater increases in renal
oxidative stress and tubular ultrastructure injury in the ACE2/ApoE
double mutant mice with greater activation of Akt-ERK1/2 phos-
phorylated signaling. While ACE2 overexpression alleviates renal
tubular injury in ApoE-mutant mice with suppression of superoxide
generation and downregulation of the Akt-ERK phosphorylated
signaling. Strategies aimed at enhancing ACE2 action may have
important therapeutic potential for atherosclerosis and renal diseases.
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OBJECTIVES Genetic predisposition plays an important role amidst
the other risk factors in the development of atherosclerosis, a socially
signiﬁcant multifactorial disease. This study was aimed to identify
the relationship between mitochondrial DNA (mtDNA) variants and
the presence of subclinical atherosclerosis, which was deﬁned ultra-
sonographically as the abnormal increase of intima-media thickness of
common carotid arteries (cIMT).
METHODS For the accurate detection of mtDNA variants, high-
throughput sequencing of the mitochondrial genome from blood
leukocytes using the Roche 454 technology was carried out in 77
asymptomatic non-related subjects. To assess the state of the carotid
artery wall, high-resolution B-mode ultrasonography was performed
with ultrasound scanner SonoScape SSI-1000 (China) using a linear
vascular 7.5 MHz probe. The borderline values for Russian population
were used for detection of abnormal cIMT values.
RESULTS In patients with subclinical atherosclerosis, 70 mtDNA
variants have been revealed that were characterized by the prevalence
over 5% of the total sample or among patients or controls. Twenty-ﬁve
of them occurred in coding region, and 5 were located in rRNA genes,
3 in tRNA genes, 5 were missense mutations. For 5 variants charac-
terized by the increased frequency in healthy subjects there were
signiﬁcant differences from the patients with subclinical atheroscle-
rosis. Three homoplasmic mtDNA variants were found only in patients
with atherosclerosis. Six MtDNA variants were characterized by a
more than 2-fold increased frequency in patients with subclinical
atherosclerosis as compared to healthy subjects. As for 115 hetero-
plasmic mtDNA variants revealed, 15 were found both in healthy
subjects and patients with subclinical carotid atherosclerosis. Three
variants had higher frequency in healthy subjects, and two variants
had higher frequency in patients with subclinical atherosclerosis.
CONCLUSIONS The data obtained in our study can be used to assess
individual risk of atherosclerosis and for further studies on the role of
mitochondrial genome mutations in the development of atheroscle-
rosis and its clinical manifestations. The individual proﬁle of certain
mtDNA variants may partially explain atherosclerosis variability and
genetic predisposition to atherosclerosis in population, which could
be inherited by maternal line.
This study was supported by Russian Scientiﬁc Foundation, Grant
No. 14-14-01038.
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OBJECTIVES Long non-coding RNAs (lncRNAs) have been found to be
involved in coronary artery disease (CAD) development. Whether ornot circulating lncRNAs work as a CAD biomarker, needs to be
established.
METHODS Using microarray-based lncRNA expression proﬁling to
explore the lncRNA expression in the circulating peripheral blood
monocyte (PBMCs) and plasma from 15 CAD patients and 15 control
subjects. After criteria (average normalized intensity is more than 7
with signiﬁcance less than 0.005) based selection, and conﬁrmed by
quantitative RT-PCR. Using the analysis of the area under the curve
(AUC) of the receiver operating characteristic (ROC) in large amount of
population. Functional enrichment analysis was performed by GO and
pathway analysis. Further validation using the speciﬁc siRNA in the
THP-1 cell line, and the concentrations of pro-inﬂammatory cytokines
(IL-1b, IL-6 and TNFa) in the culture media, were studied by ELISA.
RESULTS According to the array in the PBMCs and plasma, we found
86 lncRNAs that were differentially expressed in both PBMCs and
plasma from 15 CAD patients and 15 control subjects. After criteria and
conﬁrmed by quantitative RT-PCR, only three lncRNAs (CoroMarker,
BAT5 and IL21R-AS1) remained in the select candidate list. By ROC
analysis, CoroMarker was found to be the best candidate biomarker
for CAD with an AUC of 0.920, 95% CI 0.892-0.947. CoroMarker was
independent from CAD risk factors and other cardiovascular diseases.
In a prospective study, we found the sensitivity and speciﬁcity of
CoroMarker were 76% and 92.5%, respectively. Functional enrichment
analysis showed CoroMarker being clustered with small molecule
metabolic process and the signal transduction signaling pathway.
Further validation using the speciﬁc siRNA in the THP-1 cell line, the
concentrations of pro-inﬂammatory cytokines (IL-1b, IL-6 and TNFa)
in the culture media, were reduced signiﬁcantly.
CONCLUSIONS The present study suggests that CoroMarker have an
unanticipated role in inﬂammatory response to ﬁnally impact in the
risk of CAD, and be a novel and speciﬁc functional biomarker for the
diagnosis of CAD.GW26-e1064
Captopril negatively regulated apamin sensitive SK channels in volume-
overload rats
Yajuan Ni,1 Hongyuan Bai,2 Aiqun Ma2
1Department of Cardiology, Second Afﬁliated Hospital, Xian Jiaotong
University School of Medicine, 157 West Fifth Road, Xi’an, Shaanxi
710004, China; 2Department of Cardiology, First Afﬁliated Hospital of
Xi’an Jiaotong University School of Medicine, No.277, West Yanta Road,
Xi’an, Shaanxi 710061, China
OBJECTIVES Our previous study conﬁrmed that in heart failure the
expression and function of SK channels upregulated signiﬁcantly and
participated in electrical remodeling of cardiocytes, but the regulation
of SK channels was poorly understood in this process. Studies indi-
cated that the sensitivity of SK channels to [Ca2þ]i is positively
regulated by PP2A, which is activated by angiotensin II in many bio-
logical response paths. In the present study, we explored the effect of
angiotensin converting enzyme inhibitor captopril on apamin sensi-
tive SK channels in HF.
METHODS We used volume-overload induced heart failure rat model
by aortocaval ﬁstulas (HF group), and captopril was administrated by
gavage (CAF group). Whole-cell patch clamp was performed to
recording IKAS (Apamin sensitive current), and I-V curve was applied
to determine the the effect of captopril on IKAS. We also explored the
effect of captopril on the sensitivety of SK channels to [Ca2þ]i by
setting various [Ca2þ]i (10, 100, 500, 900,10,000 nM) at single isolated
cells, and the Hill equation (y¼1/[1þ (EC50/x)n]) was employed to
ﬁtted currents data(EC50 represents the [Ca2þ]i concentration at
halfmaximal activation of IKAS, n represents the Hill coefﬁcient). And
immunoﬂuorescent staining, real time PCR, western blot were also
carried out to furtherly investigate the underlying molecular mecha-
nism of the regulation.
RESULTS Captopril signiﬁcantly decreased the mean IKAS density at
0 mV (CAF 5.40  1.11 pA/pF, n ¼ 6 cells from 5 rats vs HF 8.90  1.79
pA/pF, n ¼ 5 cells from 6 rats P<0.05) when [Ca2þ]i at 900 nM
comparing with HF group, and obviously shifted down the I-V curve.
Similarly, the IKAS density was markedly downregulated by captopril
when [Ca2þ]i at 500, 1000, 10000nM (500 nM: CAF 4.21  0.16 pA/pF,
n ¼ 6 cells from 4 rats vs HF 7.98  0.43 pA/pF, n ¼ 6 cells from 6 rats
P<0.05; 1000nM: CAF 5.51  0.71 pA/pF, n ¼ 6 cells from 6 rats vs HF
8.96  0.51 pA/pF, n ¼ 6 cells from 5 rats P<0.05; 10000nM: CAF 5.80
 0.52 pA/pF, n ¼ 5 cells from 3 rats vs HF 9.02  0.57 pA/pF, n ¼ 5
cells from 4 rats P<0.05), the data of the Hill ﬁtting showed the sig-
niﬁcant difference in EC50 values and the Hill coefﬁcients among
the three group cells (EC50 CAF 313  17 nM, HF 231  11 nM, P<0.05;
